Trials / Withdrawn
WithdrawnNCT05543590
Effect of Plasmapheresis on Clinical Improvement and Biological Parameters of Patients With Long-haul COVID
Effect of Plasmapheresis on Clinical Improvement and Biological Parameters of Patients With Long-haul COVID: PLEXCOVIL Study, a Randomized Controlled Study.
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Hôpital Européen Marseille · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Many patients infected with SARS-Cov-2 present in the months following infection with non-specific symptoms such as non-resolving fatigue, cognitive disorders, dyspnea, headaches, myalgias, sleep disorders, anosmia/ ageusia and post exertion malaise. The persistence of these symptoms is called "post covid syndrome" or "long Covid". According to the literature, the pathophysiological mechanisms involved in post-covid syndromes would include an inadequate immune response, activation of autoimmunity, persistence of pro-inflammatory biomarkers, endothelial dysfunction and alterations in the intestinal microbiota. In view of the involved pathophysiological mechanisms, linked to the circulation of pro-inflammatory molecules, autoimmunity or endothelial activation, the role of immuno-modulation in the treatment of long Covid need to be evaluated. Plasma exchange (PE) by decreasing blood levels of pro-inflammatory cytokines and/or autoimmune markers results in moderate to marked clinical improvement in various types of autoantibody-associated inflammatory, autoimmune and neurological diseases. The goal of our study is to evaluate the effects of plasmapheresis in patients with moderate to severe long-term COVID compared to patients receiving no treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Plasmapheresis | 5 sessions of plasma exchanges |
| OTHER | Blood collection | Blood collection to assess biological markers at baseline, M3 and M12 |
| OTHER | Stool samples | Stool samples will be collected from participants at baseline,M3 and M12 |
| OTHER | PET scan | PET scan at baseline and M6 |
| OTHER | Cycle ergometer stress test | Cycle ergometer stress test at M6 |
| OTHER | Questionnaires at baseline | Questionnaires at baseline, M3 and M6 |
| OTHER | Medical consultations | Medical consultations |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2025-02-01
- Completion
- 2025-10-01
- First posted
- 2022-09-16
- Last updated
- 2023-08-14
Source: ClinicalTrials.gov record NCT05543590. Inclusion in this directory is not an endorsement.